In addition, breast cancer patients with diabetes were more likely to have larger tumor size, later pathological stages, a higher rate of lymph node metastasis, and a higher rate of ER-negative expression, which was also consistent with the findings of Hou et al. [25]. This evidence concerns the gene ESR1 and breast carcinoma.